<http://semanticscience.org/resource/SIO_010383> <http://www.w3.org/2000/01/rdf-schema#label> "drug regulatory authority"@en <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_010383> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://semanticscience.org/resource/SIO_000619> <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_010383> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_010383> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://semanticscience.org/ontology/sio.owl> <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_010383> <http://purl.org/dc/elements/1.1/identifier> "SIO_010383" <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_010383> <http://purl.org/dc/terms/description> "A drug regulatory authority is a regulatory authority which acts to control what substances may be used to treat individuals."@en <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001005> <http://purl.org/dc/elements/1.1/identifier> "SIO_001005" <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001005> <http://purl.org/dc/terms/description> "A drug effect is a chemical interaction in which a chemical elicits a marked characteristic of a biological system."@en <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001005> <http://www.w3.org/2000/01/rdf-schema#label> "drug effect"@en <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001005> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001005> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://semanticscience.org/ontology/sio.owl> <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001005> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B654fad80610870eb06fd3449af288825 <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001005> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://semanticscience.org/resource/SIO_010013> <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_010038> <http://purl.org/dc/elements/1.1/identifier> "SIO_010038" <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_010038> <http://www.w3.org/2000/01/rdf-schema#label> "drug"@en <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_010038> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://semanticscience.org/resource/SIO_011125> <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_010038> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_010038> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://semanticscience.org/ontology/sio.owl> <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_010038> <http://purl.org/dc/terms/description> "A drug is a chemical entity that regulates a biological process."@en <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001006> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001006> <http://purl.org/dc/elements/1.1/identifier> "SIO_001006" <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001006> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B415681fbe0d33e25c62a4060b654c477 <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001006> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://semanticscience.org/resource/SIO_001005> <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001006> <http://purl.org/dc/terms/description> "A drug-drug interaction is an interaction in which two drugs interact in such a way to produce a non-additive biological response."@en <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001006> <http://www.w3.org/2000/01/rdf-schema#label> "drug drug interaction"@en <http://semanticscience.org/ontology/sio.owl> .
<http://semanticscience.org/resource/SIO_001006> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://semanticscience.org/ontology/sio.owl> <http://semanticscience.org/ontology/sio.owl> .
<http://www.demcare.eu/ontologies/demlab.owl#PrepareDrugBoxTask> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.demcare.eu/ontologies/demlab.owl#SemiDirectedTask> <http://www.demcare.eu/ontologies/demlab.owl> .
<http://www.demcare.eu/ontologies/demlab.owl#PrepareDrugBoxTask> <http://www.w3.org/2000/01/rdf-schema#comment> "- 4 types of drugs are proposed to the participant. \n- The participant has to respect the posology prescribed (2 types of drugs at different moment of the day) and the date (day and moment of the day)."@en <http://www.demcare.eu/ontologies/demlab.owl> .
<http://www.demcare.eu/ontologies/demlab.owl#PrepareDrugBoxTask> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://www.demcare.eu/ontologies/demlab.owl> .
<http://www.ontotext.com/proton/protonext#Drug> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.ontotext.com/proton/protonext#ChemicalCompound> <http://www.ontotext.com/proton/protonext> .
<http://www.ontotext.com/proton/protonext#Drug> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://www.ontotext.com/proton/protonext> .
<http://www.ontotext.com/proton/protonext#Drug> <http://www.w3.org/2000/01/rdf-schema#label> "Drug"@en <http://www.ontotext.com/proton/protonext> .
<http://www.ontotext.com/proton/protonext#Drug> <http://www.w3.org/2000/01/rdf-schema#comment> "A chemical substance used to improve the health condition of a person, animal, etc. For example, Aspirin, Viagra, etc."@en <http://www.ontotext.com/proton/protonext> .
<http://www.ontotext.com/proton/protonext#Announcement> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.ontotext.com/proton/protonext#PublishedMaterial> <http://www.ontotext.com/proton/protonext> .
<http://www.ontotext.com/proton/protonext#Announcement> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://www.ontotext.com/proton/protonext> .
<http://www.ontotext.com/proton/protonext#Announcement> <http://www.w3.org/2000/01/rdf-schema#comment> "A formal public statement; \"the government made an announcement about the changes in the drug war\" ; \"a declaration of independence\".) WordNet 1.7.1"@en <http://www.ontotext.com/proton/protonext> .
<http://www.ontotext.com/proton/protonext#Announcement> <http://www.w3.org/2000/01/rdf-schema#label> "Announcement"@en <http://www.ontotext.com/proton/protonext> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0040> <http://www.geneontology.org/formats/oboInOwl#hasDbXref> "IAO:0000124" <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0040> <http://www.geneontology.org/formats/oboInOwl#hasDbXref> "SNOMEDCT:404204005" <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0040> <http://purl.org/dc/elements/1.1/description> "A drug-drug interaction is a drug interaction in which two drugs interact in such a way to produce an abnormal phenotypic event."@en <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0040> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0304> <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0040> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0040> <http://www.w3.org/2000/01/rdf-schema#label> "drug-drug interaction"@en <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0043> <http://www.geneontology.org/formats/oboInOwl#hasDbXref> "MSH:D004362" <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0043> <http://www.w3.org/2000/01/rdf-schema#label> "adverse drug event"@en <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0043> <http://purl.org/dc/elements/1.1/description> "An adverse drug event is a any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom,or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product."@en <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0043> <http://www.geneontology.org/formats/oboInOwl#hasDbXref> "SNOMEDCT:406644009" <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0043> <http://www.geneontology.org/formats/oboInOwl#hasDbXref> "sider:side_effects" <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0043> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0043> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0061> <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0043> <http://purl.obolibrary.org/obo/IAO_0000119> "CDISC glossary" <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0050> <http://www.geneontology.org/formats/oboInOwl#hasDbXref> "IAO:0000124" <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0050> <http://purl.org/dc/elements/1.1/description> "Drug efficacy is a measure of the capabilty of a drug to produce an intended effect as a function of its concentration."@en <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0050> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0100> <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0050> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0050> <http://www.w3.org/2000/01/rdf-schema#label> "drug efficacy"@en <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0304> <http://www.geneontology.org/formats/oboInOwl#hasDbXref> "pharmgkb:DrugGeneVariantInteraction" <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0304> <http://purl.org/dc/elements/1.1/description> "A drug interaction is a process in which a drug interacts with a living system in such a way that it affects its behaviour."@en <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0304> <http://www.geneontology.org/formats/oboInOwl#hasDbXref> "pharmgkb:Association" <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0304> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.ifomis.org/bfo/1.1/span#ProcessualEntity> <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0304> <http://www.w3.org/2000/01/rdf-schema#label> "drug interaction"@en <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0304> <http://www.geneontology.org/formats/oboInOwl#hasDbXref> "drugbank:drug_interactions" <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0304> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0033> <http://www.w3.org/2000/01/rdf-schema#label> "drug measure"@en <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0033> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0010> <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0033> <http://purl.org/dc/elements/1.1/description> "A drug measure is a biomedical measure that describes or is a measure of drugs or their activies."@en <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0033> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://www.w3.org/2001/sw/hcls/ns/transmed/> .
<http://purl.obolibrary.org/obo/OBI_0000040> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000040> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/BFO_0000023> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000040> <http://purl.obolibrary.org/obo/IAO_0000111> "drug role"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000040> <http://purl.obolibrary.org/obo/IAO_0000117> "Role Branch"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000040> <http://purl.obolibrary.org/obo/IAO_0000119> "OBI, CDISC"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000040> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000040> <http://purl.obolibrary.org/obo/IAO_0000115> "a role borne by a molecular entity and is realized in a process of absorption by an organism  alters, or effects  (or is assumed to effect) a function(s) which inhere in an organism"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000040> <http://www.w3.org/2000/01/rdf-schema#label> "drug role"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000040> <http://purl.obolibrary.org/obo/IAO_0000112> "http://www.answers.com/topic/drug\n   1. A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication.\n   2. Such a substance as recognized or defined by the U.S. Food, Drug, and Cosmetic Act." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000040> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:Bc6521e9e682e948c1b68d1317562d600 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000040> <http://purl.obolibrary.org/obo/IAO_0000118> "drug" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://www.w3.org/2000/01/rdf-schema#comment> "1. The term 'line' is used when a culture has undergone an intentional experimental process to establish a more uniform and stable population of cells (see 'establishing cell line'). This will require one or more passages, but may involve additional selection processes. Through such passaging and/or selection processes, the resulting 'line' attains some level of genetic stability and compositional homogeneity which is typically absent in primary cultures. Because of their relative homogeneity, 'lines' are capable of being characterized and stably propagated over a period of time. A *new* cell line can be \"established\" not only through the passaging/selection of a primary culture, but also through experimental modifications of existing lines (e.g. immortalization, stable genetic modifications, drug selection for a resistant subset, etc.).  As defined here,  'cell line' can refer to a population of cells in active culture, applied experimentally, or stored in a quescent state for future use. \n\n2. The definitional criteria provided here for the 'cell line' class demarcates populations that represent what researchers actually use in the practice of science - e.g. as inputs to culturing, experimentation, and sharing. The definition is such that cell lines will exhibit important attributes. For example, they will have a relatively homogenous cell type composition as they have experienced similar selective pressures due to their continuous co-propagation. In addition, these populations can also be characterized by a passage number, again owing to their common passaging history.?\n\n3. Definitinal criteria are intended to be sufficiently clear to specify what are and what are not instances of 'cell lines' in the real world. A 'HeLa cell line' would be a subset of all HeLa cells in the world - specifically any subset that has been derived through a shared continuous lineage wherein the cells have always been passaged together and thereby evolved together through the selective pressures imposed by this common history. Accordingly, 'HeLa cell line' would not be used to refer to the collection of all HeLa cells in a given lab, or all HeLa cells in the ATCC repository, as cells in these collections will likely not all share a common culture history. Rather, 'HeLa cell line' could refer to the collection of cells I am culturing at a given moment, or that I apply in an experiment (as such collections typically meet the criteria of having a shared propagation history).  As noted above, it is such collections that are typically referred to in scientific discourse and publications.\n\n4. Notably, the term 'line' has been alternately used by other terminologies and communities to refer to cultures that have been immortalized - ie has attained the capacity for indefinite propagation in vitro.  In this ontology, we refer to such cell lines as 'immortal cell lines', and use the term 'cell line' to indicate any culture that has been passaged." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://purl.obolibrary.org/obo/IAO_0000118> "cell line sample" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://purl.obolibrary.org/obo/IAO_0000119> "OBI-CLO Alignment Working Group (Spring 2013)" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://www.w3.org/2000/01/rdf-schema#label> "obsolete_cell line"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.geneontology.org/formats/oboInOwl#ObsoleteClass> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://purl.obolibrary.org/obo/IAO_0000231> <http://purl.obolibrary.org/obo/IAO_0000228> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://purl.obolibrary.org/obo/IAO_0000117> "PERSON:Matthew Brush" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://purl.obolibrary.org/obo/IAO_0000112> "A split of HeLa cells in active culture, or stored in frozen aliquots. Populations of HEK 293 cells used in experiments such as those documented in \"Changes in ultrastructure and endogenous ionic channels activity during culture of HEK 293 cell line\". Eur J Pharmacol. 2007 Jul 12;567(1-2):10-8. PMID: 17482592." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://purl.obolibrary.org/obo/IAO_0100001> "http://purl.obolibrary.org/obo/CLO_0000031" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://www.w3.org/2002/07/owl#deprecated> "true"^^<http://www.w3.org/2001/XMLSchema#boolean> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://purl.obolibrary.org/obo/IAO_0000111> "cell line" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://purl.obolibrary.org/obo/IAO_0000115> "A secondary cultured cell population that represents a genetically stable and homogenous population of cultured cells that shares a common propagation history (ie has been successively passaged together in culture).  " <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://purl.obolibrary.org/obo/IAO_0000112> "He, Tong-Chuan, et al. \\\"Identification of c-MYC as a target of the APC pathway.\\\" Science 281.5382 (1998): 1509-1512. - \\\"To evaluate the transcriptional effects of APC, we studied a human colorectal cancer cell line (HT29-APC) containing a zinc-inducible APC gene and a control cell line (HT29–β-Gal) containing an analogous inducible lacZ gene\\\".\n\nNote that common usage in the literature is often of the form \\\"a human colorectal cancer cell line\\\", as seen above. But such references to studies in \\\"a line\\\" refer to the fact that discrete populations of cells that are input into culturing or experiments, not an entire lineage of cells.  It is these discrete populations that we refer to as 'cell lines'." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0100062> <http://purl.obolibrary.org/obo/IAO_0000116> "2013-08-09 MHB: Replaced with cell line class from CLO, follwoing outcome of Spring 2013 CLO alignment work.  Subclass axioms were: 'has grain' some 'cell line cell' and 'has grain' only 'cell line cell'\n\n2013-6-5 MHB: There is considerable ambiguity and inconsistent usage surrounding the term 'cell line' across biomedical communities. For exmaple, it can refer to the maximal collection of all cells in a cultured lineage (e.g. the colelction of all HeLa cells that exist), or to discrete portions of this maximal collection that are stored, exchanged, and applied experimentally (e.g. the dish of HeLa cells I am using in my experiment). A working group of representatives from OBI, CLO, and CL was assembled in spring of 2013 to harmonize modeling and terminology surrounding experimentally cultured cells across Open Biomedical Ontologies, following OBO Foundry principles of orthogonality and re-use. A consensus was reached to apply the term 'cell line' to refer not to a maximal collection of cells of a given type, but to discrete populations of cultured cells that share a common propagation history which has conferred a certain a genetic stability and compositional homogeneity to the population.  This meaning reflects its most common usage in domain discourse, and will best support data annotation requirements. This view means that a 'HeLa cell line' would be a subset of all HeLa cells in the world - specifically<http://purl.obolibrary.org/obo/OBI_0000901> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000901> <http://purl.obolibrary.org/obo/IAO_0000118> "FDA" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000901> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> _:B6ec5557682a4388fd8ba155e2739f289 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000901> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.obolibrary.org/obo/OBI_0000245> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000901> <http://purl.obolibrary.org/obo/IAO_0000111> "U.S. Food and Drug Administration" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000901> <http://www.w3.org/2000/01/rdf-schema#label> "U.S. Food and Drug Administration" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000901> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000123> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002431> <http://purl.obolibrary.org/obo/IAO_0000117> "Chris Stoeckert, Helena Ellis" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002431> <http://purl.obolibrary.org/obo/IAO_0000119> "NCI BBRB, OBIB" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002431> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002431> <http://purl.obolibrary.org/obo/IAO_0000115> "An exclusion criterion defined as when an individual has a history of intravenous drug abuse for a specific timeframe, which if met, makes the individual unsuitable for a given task or participation in a given process." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002431> <http://purl.obolibrary.org/obo/IAO_0000111> "intravenous drug use exclusion criterion" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002431> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500028> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002431> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002431> <http://purl.obolibrary.org/obo/IAO_0000112> "Donor eligibility based on history of intravenous drug abuse in the last 5 years." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002431> <http://www.w3.org/2000/01/rdf-schema#label> "intravenous drug use exclusion criterion" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002431> <http://purl.obolibrary.org/obo/IAO_0000234> "NCI BBRB" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002433> <http://purl.obolibrary.org/obo/IAO_0000111> "history of sex with someone with a history of intravenous drugs exclusion criterion" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002433> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500028> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002433> <http://purl.obolibrary.org/obo/IAO_0000115> "An exclusion criterion defined  as whether an individual has a history of sex with someone who has used intravenous drugs in a specified time frame, which if met, makes the individual unsuitable for a given task or participation in a given process." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002433> <http://purl.obolibrary.org/obo/IAO_0000119> "NCI BBRB, OBIB" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002433> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002433> <http://purl.obolibrary.org/obo/IAO_0000117> "Chris Stoeckert, Helena Ellis" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002433> <http://purl.obolibrary.org/obo/IAO_0000234> "NCI BBRB" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002433> <http://www.w3.org/2000/01/rdf-schema#label> "history of sex with someone with a history of intravenous drugs exclusion criterion" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002433> <http://purl.obolibrary.org/obo/IAO_0000112> "Donor eligibility based on whether the donor has a history of sex with someone who has used intravenous drugs in the last 5 years." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002433> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.org/net/hifm/ontology#Drug> <http://www.w3.org/2000/01/rdf-schema#comment> "This class represents a brand-name drug." <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#Drug> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#strength> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#strength> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#strength> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/hifm/ontology#Drug> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#strength> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the strength of the drug, in milligrams." <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#packaging> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#packaging> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the number of units per drug package." <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#packaging> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/hifm/ontology#Drug> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#packaging> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#nonNegativeInteger> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#similarTo> <http://www.w3.org/2000/01/rdf-schema#range> <http://purl.org/net/hifm/ontology#Drug> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#similarTo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#TransitiveProperty> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#similarTo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#similarTo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#SymmetricProperty> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#similarTo> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/hifm/ontology#Drug> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#similarTo> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents a similarity that is known between two drugs." <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#manufacturer> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/hifm/ontology#Drug> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#manufacturer> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents a manufacturer of a drug." <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#manufacturer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/hifm/ontology#manufacturer> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/hifm/ontology#> .
<http://purl.org/net/dbm/ontology#Drug> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#Drug> <http://www.w3.org/2000/01/rdf-schema#comment> "This class represents a Drug entity from the Macedonian Drug Bureau." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#manufacturer> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#manufacturer> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#manufacturer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#manufacturer> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents a manufacturer of a drug." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#approvedOn> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the date the company was given the approval by the Macedonian Drug Bureau for the drug." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#approvedOn> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#approvedOn> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#approvedOn> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#dateTime> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#referencePrice> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#referencePrice> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#referencePrice> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#float> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#referencePrice> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the reference price for the drug, as assigned by the Ministry of Health of the Republic of Macedonia." <http://purl.org/net/dbm/ontology#> .
<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/brandName> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/brandName> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/brandName> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the brand name of the drug." <http://purl.org/net/dbm/ontology#> .
<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/brandName> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/atcCode> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the ATC code of the drug." <http://purl.org/net/dbm/ontology#> .
<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/atcCode> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/atcCode> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/atcCode> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#packaging> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#packaging> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#packaging> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#packaging> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the packaging information of the drug." <http://purl.org/net/dbm/ontology#> .
<http://www.w3.org/2000/01/rdf-schema#label> <http://www.w3.org/2000/01/rdf-schema#comment> "This property holds the brand name of the drug, as a label." <http://purl.org/net/dbm/ontology#> .
<http://www.w3.org/2000/01/rdf-schema#label> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://www.w3.org/2000/01/rdf-schema#label> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://www.w3.org/2000/01/rdf-schema#label> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#updateDate> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#dateTime> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#updateDate> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#updateDate> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#updateDate> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the date the drug data has been updated." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#eanCode> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#eanCode> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#FunctionalProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#eanCode> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#eanCode> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#eanCode> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the EAN code of the drug." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#strength> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#strength> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#strength> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#strength> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the strength of the drug." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#brailleSupport> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#brailleSupport> <http://www.w3.org/2000/01/rdf-schema#comment> "This property indicates wether the drug packaging has Braille support or not." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#brailleSupport> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#brailleSupport> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#priceWithVAT> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the price of the drug in Macedonian Denars (MKD), with VAT calculated." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#priceWithVAT> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#float> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#priceWithVAT> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#priceWithVAT> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#brandNameCyrillic> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#brandNameCyrillic> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#brandNameCyrillic> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the brand name of the drug, in cyrillic alphabet." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#brandNameCyrillic> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#summaryReport> <http://www.w3.org/2000/01/rdf-schema#comment> "This property holds the URL to the summary report for the drug, published by the Macedonian Drug Bureau." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#summaryReport> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#summaryReport> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#summaryReport> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#FunctionalProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#summaryReport> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#positiveList> <http://www.w3.org/2000/01/rdf-schema#comment> "This property tells if the drug is featured on the positive list of drugs, or not." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#positiveList> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#positiveList> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#positiveList> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://xmlns.com/foaf/0.1/page> <http://www.w3.org/2000/01/rdf-schema#comment> "This property holds the URL of the drug information page on the Macedonian Drug Bureau website." <http://purl.org/net/dbm/ontology#> .
<http://xmlns.com/foaf/0.1/page> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://xmlns.com/foaf/0.1/page> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://xmlns.com/foaf/0.1/page> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://xmlns.com/foaf/0.1/page> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#FunctionalProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#usageGuidelines> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#usageGuidelines> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#usageGuidelines> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#FunctionalProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#usageGuidelines> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#usageGuidelines> <http://www.w3.org/2000/01/rdf-schema#comment> "This property holds the URL to the usage guidelines for the drug, published by the Macedonian Drug Bureau." <http://purl.org/net/dbm/ontology#> .
<http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.w3.org/2000/01/rdf-schema#range> <http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/drugs> <http://purl.org/net/dbm/ontology#> .
<http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.w3.org/2000/01/rdf-schema#comment> "This property links a drug from the Macedonian Drug Bureau with a drug from DrugBank, based on the ATC code." <http://purl.org/net/dbm/ontology#> .
<http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> <http://purl.org/net/dbm/ontology#> .
<http://www.w3.org/2000/01/rdf-schema#seeAlso> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/genericName> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the generic name of the drug." <http://purl.org/net/dbm/ontology#> .
<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/genericName> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/genericName> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/genericName> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#atcCodeExtended> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#atcCodeExtended> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#atcCodeExtended> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#atcCodeExtended> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the extended ATC code for the drug, assigned by the Ministry of Health, of the Republic of Macedonia." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#dosage> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#dosage> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/net/dbm/ontology#Drug> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#dosage> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#dosage> <http://www.w3.org/2000/01/rdf-schema#comment> "This property represents the dosage information for the drug." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://purl.org/dc/terms/issued> "2014-09-01" <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://purl.org/dc/terms/publisher> <http://finki.ukim.mk/> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://purl.org/dc/terms/rights> "Copyright 2014, Milos Jovanovik" <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/net/dbm/ontology> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://purl.org/vocab/vann/preferredNamespacePrefix> "dbm" <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Ontology> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://purl.org/vocab/vann/preferredNamespaceUri> "http://purl.org/net/dbm/ontology#" <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://purl.org/dc/terms/title> "DBM Ontology" <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://purl.org/dc/terms/description> "An ontology for describing brand-name drugs." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://purl.org/dc/terms/creator> <https://plus.google.com/+MilosJovanovik> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://purl.org/dc/terms/modified> "2016-08-28" <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://creativecommons.org/ns#license> <https://creativecommons.org/licenses/by/3.0/> <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://www.w3.org/2000/01/rdf-schema#label> "DBM Ontology" <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://www.w3.org/2000/01/rdf-schema#comment> "An ontology for the Drug Bureau of Macedonia (DBM)." <http://purl.org/net/dbm/ontology#> .
<http://purl.org/net/dbm/ontology#> <http://www.w3.org/2002/07/owl#versionInfo> "1.1" <http://purl.org/net/dbm/ontology#> .
<http://data.cochrane.org/ontologies/core/Drug> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://data.cochrane.org/ontologies/core/Material> <http://data.cochrane.org/ontologies/core/> .
<http://data.cochrane.org/ontologies/core/Drug> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://data.cochrane.org/ontologies/core/> <http://data.cochrane.org/ontologies/core/> .
<http://data.cochrane.org/ontologies/core/Drug> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://data.cochrane.org/ontologies/core/> .
<http://data.cochrane.org/ontologies/core/Drug> <http://www.w3.org/2000/01/rdf-schema#label> "Drug"@en <http://data.cochrane.org/ontologies/core/> .
<http://data.cochrane.org/ontologies/core/Drug> <http://www.w3.org/2000/01/rdf-schema#comment> "A Drug used as intervention"@en <http://data.cochrane.org/ontologies/core/> .
